← FDA Drug Approvals (Drugs@FDA)
SODIUM SULFATE, POTASSIUM SULFATE AND MAGNESIUM SULFATE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: STRIDES PHARMA INTL · Approved 2023-11-22
Drug application
- FDA Application #
ANDA215469- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- SODIUM SULFATE, POTASSIUM SULFATE AND MAGNESIUM SULFATE
- Generic name
- SODIUM SULFATE, POTASSIUM SULFATE AND MAGNESIUM SULFATE ORAL
- Active ingredients
- MAGNESIUM SULFATE; POTASSIUM SULFATE; SODIUM SULFATE
- Dosage form
- SOLUTION
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- STRIDES PHARMA INTL
- Manufacturer
- Strides Pharma Science Limited
- First approval
- 2023-11-22
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown